Drug Markets/Mexiletine Hydrochloride

Mexiletine Hydrochloride

23 NDCs across 9 manufacturers|23 Generic,0 Brand

Mexiletine Hydrochloride is used to treat diabetic neuropathies, ventricular fibrillation and ventricular premature complexes, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 30, 1985, and the first generic was approved May 16, 1995. FDA's Orange Book lists 27 AB-rated (therapeutically equivalent) products for this ingredient.

Mexiletine Hydrochloride is available as 23 NDCs from 9 manufacturers (23 generic, 0 brand), with NADAC prices from $0.22 to $0.39 per EA — a 74% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

23

23G / 0B

Manufacturers

9

competing in market

Price Spread

$0.22 – $0.39

per EA

7d Activity

23↓0 flat

avg -1.8% WoW · of 23 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

23 NDCs total, 23 shown

Drug ↕Price 7d Change ↕
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 250 MG CAPSULE
$0.3872
per EA
-1.67%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 200 MG CAPSULE
$0.2574
per EA
-2.01%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%
MEXILETINE 150 MG CAPSULE
$0.2225
per EA
-1.80%

Frequently Asked Questions

What is Mexiletine Hydrochloride used to treat?

Mexiletine Hydrochloride is used to treat diabetic neuropathies, ventricular fibrillation and ventricular premature complexes, per the National Library of Medicine's MED-RT classification.

When did Mexiletine Hydrochloride become available as a generic?

FDA approved the first generic Mexiletine Hydrochloride (ANDA) on May 16, 1995. The Orange Book currently lists 27 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How many Mexiletine Hydrochloride products are on the market?

The Mexiletine Hydrochloride drug market contains 23 NDCs from 9 manufacturers — 23 generic and 0 brand products.

What is the price range for Mexiletine Hydrochloride?

NADAC reference prices for Mexiletine Hydrochloride range from $0.2225 to $0.3872 per EA — a 74% difference between cheapest and most expensive.

Which manufacturers make Mexiletine Hydrochloride?

9 manufacturers list Mexiletine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Rising Pharma Holdings Inc. (3), Teva Pharmaceuticals USA Inc. (3), Lannett Company Inc. (3), Camber Pharmaceuticals Inc. (3), Ingenus Pharmaceuticals LLC (3).

How has the price of Mexiletine Hydrochloride changed recently?

Over the past 7 days, 0 Mexiletine Hydrochloride NDCs rose and 23 fell, with a market-wide average change of -1.8%.